ID   TBL1R_HUMAN             Reviewed;         514 AA.
AC   Q9BZK7; D3DNQ9; Q14DC3; Q9H2I1; Q9H9A1;
DT   19-SEP-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   15-MAR-2017, entry version 157.
DE   RecName: Full=F-box-like/WD repeat-containing protein TBL1XR1;
DE   AltName: Full=Nuclear receptor corepressor/HDAC3 complex subunit TBLR1;
DE   AltName: Full=TBL1-related protein 1;
DE   AltName: Full=Transducin beta-like 1X-related protein 1;
GN   Name=TBL1XR1; Synonyms=IRA1, TBLR1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], IDENTIFICATION BY MASS SPECTROMETRY, AND
RP   COMPONENT OF THE N-COR COMPLEX WITH NCOR1; NCOR2; GPS2; TBL1X AND
RP   HDAC3.
RX   PubMed=11931768; DOI=10.1016/S1097-2765(02)00468-9;
RA   Zhang J., Kalkum M., Chait B.T., Roeder R.G.;
RT   "The N-CoR-HDAC3 nuclear receptor corepressor complex inhibits the JNK
RT   pathway through the integral subunit GPS2.";
RL   Mol. Cell 9:611-623(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=11063877; DOI=10.1016/S0301-472X(00)00539-7;
RA   Zhang X., Dormady S.P., Basch R.S.;
RT   "Identification of four human cDNAs that are differentially expressed
RT   by early hematopoietic progenitors.";
RL   Exp. Hematol. 28:1286-1296(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Adrenal cortex, and Liver;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   COMPONENT OF THE N-COR COMPLEX WITH TBL1X; CORO2A AND HDAC3, AND
RP   HISTONE-BINDING.
RX   PubMed=12628926; DOI=10.1093/emboj/cdg120;
RA   Yoon H.-G., Chan D.W., Huang Z.-Q., Li J., Fondell J.D., Qin J.,
RA   Wong J.;
RT   "Purification and functional characterization of the human N-CoR
RT   complex: the roles of HDAC3, TBL1 and TBLR1.";
RL   EMBO J. 22:1336-1346(2003).
RN   [7]
RP   FUNCTION, AND RECRUITMENT OF 19S PROTEASOME COMPLEX.
RX   PubMed=14980219; DOI=10.1016/S0092-8674(04)00133-3;
RA   Perissi V., Aggarwal A., Glass C.K., Rose D.W., Rosenfeld M.G.;
RT   "A corepressor/coactivator exchange complex required for
RT   transcriptional activation by nuclear receptors and other regulated
RT   transcription factors.";
RL   Cell 116:511-526(2004).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-119, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [12]
RP   INVOLVEMENT IN MRD41, AND VARIANT MRD41 PRO-282.
RX   PubMed=22495309; DOI=10.1038/nature10989;
RA   O'Roak B.J., Vives L., Girirajan S., Karakoc E., Krumm N., Coe B.P.,
RA   Levy R., Ko A., Lee C., Smith J.D., Turner E.H., Stanaway I.B.,
RA   Vernot B., Malig M., Baker C., Reilly B., Akey J.M., Borenstein E.,
RA   Rieder M.J., Nickerson D.A., Bernier R., Shendure J., Eichler E.E.;
RT   "Sporadic autism exomes reveal a highly interconnected protein network
RT   of de novo mutations.";
RL   Nature 485:246-250(2012).
RN   [13]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [14]
RP   INVOLVEMENT IN MRD41.
RX   PubMed=23160955; DOI=10.1126/science.1227764;
RA   O'Roak B.J., Vives L., Fu W., Egertson J.D., Stanaway I.B.,
RA   Phelps I.G., Carvill G., Kumar A., Lee C., Ankenman K., Munson J.,
RA   Hiatt J.B., Turner E.H., Levy R., O'Day D.R., Krumm N., Coe B.P.,
RA   Martin B.K., Borenstein E., Nickerson D.A., Mefford H.C., Doherty D.,
RA   Akey J.M., Bernier R., Eichler E.E., Shendure J.;
RT   "Multiplex targeted sequencing identifies recurrently mutated genes in
RT   autism spectrum disorders.";
RL   Science 338:1619-1622(2012).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-119, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   INVOLVEMENT IN MRD41, VARIANT MRD41 ASP-70, AND VARIANTS SER-116;
RP   GLU-405 AND SER-407.
RX   PubMed=25102098; DOI=10.1038/jhg.2014.71;
RA   Saitsu H., Tohyama J., Walsh T., Kato M., Kobayashi Y., Lee M.,
RA   Tsurusaki Y., Miyake N., Goto Y., Nishino I., Ohtake A., King M.C.,
RA   Matsumoto N.;
RT   "A girl with West syndrome and autistic features harboring a de novo
RT   TBL1XR1 mutation.";
RL   J. Hum. Genet. 59:581-583(2014).
RN   [17]
RP   INVOLVEMENT IN MRD41, AND VARIANT MRD41 CYS-245.
RX   PubMed=27133561; DOI=10.1002/ajmg.a.37684;
RG   FORGE Canada Consortium;
RA   Armour C.M., Smith A., Hartley T., Chardon J.W., Sawyer S.,
RA   Schwartzentruber J., Hennekam R., Majewski J., Bulman D.E., Suri M.,
RA   Boycott K.M.;
RT   "Syndrome disintegration: Exome sequencing reveals that Fitzsimmons
RT   syndrome is a co-occurrence of multiple events.";
RL   Am. J. Med. Genet. A 170:1820-1825(2016).
RN   [18]
RP   TISSUE SPECIFICITY, INVOLVEMENT IN PRPTS, VARIANT PRPTS CYS-446, AND
RP   CHARACTERIZATION OF VARIANT PRPTS CYS-446.
RX   PubMed=26769062; DOI=10.1136/jmedgenet-2015-103233;
RA   Heinen C.A., Jongejan A., Watson P.J., Redeker B., Boelen A.,
RA   Boudzovitch-Surovtseva O., Forzano F., Hordijk R., Kelley R.,
RA   Olney A.H., Pierpont M.E., Schaefer G.B., Stewart F.,
RA   van Trotsenburg A.S., Fliers E., Schwabe J.W., Hennekam R.C.;
RT   "A specific mutation in TBL1XR1 causes Pierpont syndrome.";
RL   J. Med. Genet. 53:330-337(2016).
RN   [19]
RP   ERRATUM.
RX   PubMed=27221108; DOI=10.1136/jmedgenet-2015-103233corr1;
RA   Heinen C.A., Jongejan A., Watson P.J., Redeker B., Boelen A.,
RA   Boudzovitch-Surovtseva O., Forzano F., Hordijk R., Kelley R.,
RA   Olney A.H., Pierpont M.E., Schaefer G.B., Stewart F.,
RA   van Trotsenburg A.S., Fliers E., Schwabe J.W., Hennekam R.C.;
RL   J. Med. Genet. 53:430-430(2016).
CC   -!- FUNCTION: F-box-like protein involved in the recruitment of the
CC       ubiquitin/19S proteasome complex to nuclear receptor-regulated
CC       transcription units. Plays an essential role in transcription
CC       activation mediated by nuclear receptors. Probably acts as
CC       integral component of the N-Cor corepressor complex that mediates
CC       the recruitment of the 19S proteasome complex, leading to the
CC       subsequent proteasomal degradation of N-Cor complex, thereby
CC       allowing cofactor exchange, and transcription activation.
CC       {ECO:0000269|PubMed:14980219}.
CC   -!- SUBUNIT: Component of the N-Cor repressor complex, at least
CC       composed of NCOR1, NCOR2, HDAC3, TBL1X, TBL1XR1, CORO2A and GPS2.
CC       Probable component of some E3 ubiquitin ligase complex. Interacts
CC       with histones H2B and H4.
CC   -!- INTERACTION:
CC       P36404:ARL2; NbExp=3; IntAct=EBI-765729, EBI-752365;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Widely expressed including the pituitary,
CC       hypothalamus, white and brown adipose tissue, muscle and liver.
CC       {ECO:0000269|PubMed:26769062}.
CC   -!- DOMAIN: The F-box-like domain is related to the F-box domain, and
CC       apparently displays the same function as component of ubiquitin E3
CC       ligase complexes. {ECO:0000250}.
CC   -!- DISEASE: Pierpont syndrome (PRPTS) [MIM:602342]: An autosomal
CC       dominant syndrome characterized by multiple congenital anomalies,
CC       global developmental delay, learning disability, palmar and
CC       plantar fat pads, and distinctive facial characteristics,
CC       especially when smiling. {ECO:0000269|PubMed:26769062}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- DISEASE: Mental retardation, autosomal dominant 41 (MRD41)
CC       [MIM:616944]: A form of mental retardation, a disorder
CC       characterized by significantly below average general intellectual
CC       functioning associated with impairments in adaptive behavior and
CC       manifested during the developmental period. MRD41 patients
CC       manifest delayed psychomotor development, variable severity of
CC       intellectual disability, and delayed language. Non-specific
CC       dysmorphic features and autistic behavior is observed in some
CC       patients. {ECO:0000269|PubMed:22495309,
CC       ECO:0000269|PubMed:23160955, ECO:0000269|PubMed:25102098,
CC       ECO:0000269|PubMed:27133561}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the WD repeat EBI family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH60320.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF314544; AAK00301.1; -; mRNA.
DR   EMBL; AF268193; AAG44736.1; -; mRNA.
DR   EMBL; AK022956; BAB14331.1; -; mRNA.
DR   EMBL; CH471052; EAW78438.1; -; Genomic_DNA.
DR   EMBL; BC060320; AAH60320.1; ALT_SEQ; mRNA.
DR   EMBL; BC113421; AAI13422.1; -; mRNA.
DR   CCDS; CCDS46961.1; -.
DR   RefSeq; NP_001308122.1; NM_001321193.1.
DR   RefSeq; NP_001308123.1; NM_001321194.1.
DR   RefSeq; NP_001308124.1; NM_001321195.1.
DR   RefSeq; NP_078941.2; NM_024665.5.
DR   RefSeq; XP_005247832.1; XM_005247775.2.
DR   RefSeq; XP_006713809.1; XM_006713746.1.
DR   RefSeq; XP_011511443.1; XM_011513141.1.
DR   RefSeq; XP_011511444.1; XM_011513142.2.
DR   RefSeq; XP_011511445.1; XM_011513143.2.
DR   RefSeq; XP_016862674.1; XM_017007185.1.
DR   UniGene; Hs.714201; -.
DR   UniGene; Hs.715026; -.
DR   PDB; 4LG9; X-ray; 2.28 A; A=134-514.
DR   PDBsum; 4LG9; -.
DR   ProteinModelPortal; Q9BZK7; -.
DR   SMR; Q9BZK7; -.
DR   BioGrid; 122834; 66.
DR   DIP; DIP-34582N; -.
DR   IntAct; Q9BZK7; 28.
DR   MINT; MINT-2816883; -.
DR   STRING; 9606.ENSP00000405574; -.
DR   iPTMnet; Q9BZK7; -.
DR   PhosphoSitePlus; Q9BZK7; -.
DR   BioMuta; TBL1XR1; -.
DR   DMDM; 23396874; -.
DR   EPD; Q9BZK7; -.
DR   MaxQB; Q9BZK7; -.
DR   PaxDb; Q9BZK7; -.
DR   PeptideAtlas; Q9BZK7; -.
DR   PRIDE; Q9BZK7; -.
DR   Ensembl; ENST00000430069; ENSP00000405574; ENSG00000177565.
DR   Ensembl; ENST00000457928; ENSP00000413251; ENSG00000177565.
DR   GeneID; 79718; -.
DR   KEGG; hsa:79718; -.
DR   UCSC; uc003fiw.5; human.
DR   CTD; 79718; -.
DR   DisGeNET; 79718; -.
DR   GeneCards; TBL1XR1; -.
DR   H-InvDB; HIX0147994; -.
DR   HGNC; HGNC:29529; TBL1XR1.
DR   HPA; HPA019182; -.
DR   MalaCards; TBL1XR1; -.
DR   MIM; 602342; phenotype.
DR   MIM; 608628; gene.
DR   MIM; 616944; phenotype.
DR   neXtProt; NX_Q9BZK7; -.
DR   OpenTargets; ENSG00000177565; -.
DR   Orphanet; 520; Acute promyelocytic leukemia.
DR   PharmGKB; PA134928556; -.
DR   eggNOG; ENOG410IQU2; Eukaryota.
DR   eggNOG; COG2319; LUCA.
DR   GeneTree; ENSGT00860000133748; -.
DR   HOGENOM; HOG000220902; -.
DR   HOVERGEN; HBG050240; -.
DR   InParanoid; Q9BZK7; -.
DR   KO; K04508; -.
DR   OMA; LANNHSD; -.
DR   OrthoDB; EOG091G04MW; -.
DR   PhylomeDB; Q9BZK7; -.
DR   TreeFam; TF323190; -.
DR   Reactome; R-HSA-1368082; RORA activates gene expression.
DR   Reactome; R-HSA-1368108; BMAL1:CLOCK,NPAS2 activates circadian gene expression.
DR   Reactome; R-HSA-1989781; PPARA activates gene expression.
DR   Reactome; R-HSA-2032785; YAP1- and WWTR1 (TAZ)-stimulated gene expression.
DR   Reactome; R-HSA-2122947; NOTCH1 Intracellular Domain Regulates Transcription.
DR   Reactome; R-HSA-2151201; Transcriptional activation of mitochondrial biogenesis.
DR   Reactome; R-HSA-2426168; Activation of gene expression by SREBF (SREBP).
DR   Reactome; R-HSA-2644606; Constitutive Signaling by NOTCH1 PEST Domain Mutants.
DR   Reactome; R-HSA-2894862; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants.
DR   Reactome; R-HSA-3214815; HDACs deacetylate histones.
DR   Reactome; R-HSA-381340; Transcriptional regulation of white adipocyte differentiation.
DR   Reactome; R-HSA-400206; Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha).
DR   Reactome; R-HSA-400253; Circadian Clock.
DR   SignaLink; Q9BZK7; -.
DR   SIGNOR; Q9BZK7; -.
DR   ChiTaRS; TBL1XR1; human.
DR   GeneWiki; TBL1XR1; -.
DR   GenomeRNAi; 79718; -.
DR   PMAP-CutDB; Q9BZK7; -.
DR   PRO; PR:Q9BZK7; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000177565; -.
DR   CleanEx; HS_TBL1XR1; -.
DR   ExpressionAtlas; Q9BZK7; baseline and differential.
DR   Genevisible; Q9BZK7; HS.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005876; C:spindle microtubule; IDA:UniProtKB.
DR   GO; GO:0017053; C:transcriptional repressor complex; IDA:UniProtKB.
DR   GO; GO:0008013; F:beta-catenin binding; IPI:UniProtKB.
DR   GO; GO:0042393; F:histone binding; IDA:UniProtKB.
DR   GO; GO:0047485; F:protein N-terminus binding; IPI:UniProtKB.
DR   GO; GO:0003714; F:transcription corepressor activity; IDA:UniProtKB.
DR   GO; GO:0044212; F:transcription regulatory region DNA binding; IDA:UniProtKB.
DR   GO; GO:0060070; P:canonical Wnt signaling pathway; IMP:UniProtKB.
DR   GO; GO:0044255; P:cellular lipid metabolic process; TAS:Reactome.
DR   GO; GO:0060613; P:fat pad development; IEA:Ensembl.
DR   GO; GO:0016575; P:histone deacetylation; IBA:GO_Central.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:Ensembl.
DR   GO; GO:0035264; P:multicellular organism growth; IEA:Ensembl.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; ISS:UniProtKB.
DR   GO; GO:0030814; P:regulation of cAMP metabolic process; IEA:Ensembl.
DR   GO; GO:0090207; P:regulation of triglyceride metabolic process; IEA:Ensembl.
DR   GO; GO:0002021; P:response to dietary excess; IEA:Ensembl.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0050872; P:white fat cell differentiation; IEA:Ensembl.
DR   Gene3D; 2.130.10.10; -; 2.
DR   InterPro; IPR020472; G-protein_beta_WD-40_rep.
DR   InterPro; IPR006594; LisH.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom.
DR   InterPro; IPR001680; WD40_repeat.
DR   InterPro; IPR019775; WD40_repeat_CS.
DR   InterPro; IPR017986; WD40_repeat_dom.
DR   Pfam; PF08513; LisH; 1.
DR   Pfam; PF00400; WD40; 6.
DR   PRINTS; PR00320; GPROTEINBRPT.
DR   SMART; SM00667; LisH; 1.
DR   SMART; SM00320; WD40; 8.
DR   SUPFAM; SSF50978; SSF50978; 2.
DR   PROSITE; PS50896; LISH; 1.
DR   PROSITE; PS00678; WD_REPEATS_1; 4.
DR   PROSITE; PS50082; WD_REPEATS_2; 6.
DR   PROSITE; PS50294; WD_REPEATS_REGION; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Activator; Chromatin regulator;
KW   Complete proteome; Disease mutation; Mental retardation; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome; Repeat; Repressor;
KW   Transcription; Transcription regulation; Ubl conjugation pathway;
KW   WD repeat.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378}.
FT   CHAIN         2    514       F-box-like/WD repeat-containing protein
FT                                TBL1XR1.
FT                                /FTId=PRO_0000051266.
FT   DOMAIN        4     36       LisH. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00126}.
FT   DOMAIN       41     86       F-box-like.
FT   REPEAT      167    206       WD 1.
FT   REPEAT      223    262       WD 2.
FT   REPEAT      264    303       WD 3.
FT   REPEAT      306    344       WD 4.
FT   REPEAT      347    386       WD 5.
FT   REPEAT      389    437       WD 6.
FT   REPEAT      440    479       WD 7.
FT   REPEAT      481    513       WD 8.
FT   COMPBIAS    108    118       Poly-Ala.
FT   MOD_RES       2      2       N-acetylserine.
FT                                {ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378}.
FT   MOD_RES     102    102       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q8BHJ5}.
FT   MOD_RES     119    119       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   VARIANT      70     70       G -> D (in MRD41; dbSNP:rs786205859).
FT                                {ECO:0000269|PubMed:25102098}.
FT                                /FTId=VAR_076753.
FT   VARIANT     116    116       A -> S (in dbSNP:rs372813783).
FT                                {ECO:0000269|PubMed:25102098}.
FT                                /FTId=VAR_076754.
FT   VARIANT     245    245       Y -> C (in MRD41).
FT                                {ECO:0000269|PubMed:27133561}.
FT                                /FTId=VAR_076755.
FT   VARIANT     282    282       L -> P (in MRD41).
FT                                {ECO:0000269|PubMed:22495309}.
FT                                /FTId=VAR_076756.
FT   VARIANT     405    405       G -> E (found in a patient with epilepsy;
FT                                unknown pathological significance;
FT                                dbSNP:rs747932785).
FT                                {ECO:0000269|PubMed:25102098}.
FT                                /FTId=VAR_076757.
FT   VARIANT     407    407       N -> S (found in a patient with epilepsy;
FT                                unknown pathological significance;
FT                                dbSNP:rs781011308).
FT                                {ECO:0000269|PubMed:25102098}.
FT                                /FTId=VAR_076758.
FT   VARIANT     446    446       Y -> C (in PRPTS; does not affect
FT                                assembly into the N-Cor repressor
FT                                complex). {ECO:0000269|PubMed:26769062}.
FT                                /FTId=VAR_076759.
FT   CONFLICT     31     31       E -> K (in Ref. 2; AAG44736).
FT                                {ECO:0000305}.
FT   CONFLICT     59     59       Y -> H (in Ref. 3; BAB14331).
FT                                {ECO:0000305}.
FT   CONFLICT    389    389       A -> Q (in Ref. 2; AAG44736).
FT                                {ECO:0000305}.
FT   HELIX       159    161       {ECO:0000244|PDB:4LG9}.
FT   STRAND      162    165       {ECO:0000244|PDB:4LG9}.
FT   STRAND      172    177       {ECO:0000244|PDB:4LG9}.
FT   STRAND      179    188       {ECO:0000244|PDB:4LG9}.
FT   STRAND      191    197       {ECO:0000244|PDB:4LG9}.
FT   STRAND      208    212       {ECO:0000244|PDB:4LG9}.
FT   STRAND      228    233       {ECO:0000244|PDB:4LG9}.
FT   STRAND      237    244       {ECO:0000244|PDB:4LG9}.
FT   STRAND      247    253       {ECO:0000244|PDB:4LG9}.
FT   STRAND      258    264       {ECO:0000244|PDB:4LG9}.
FT   STRAND      269    274       {ECO:0000244|PDB:4LG9}.
FT   STRAND      276    285       {ECO:0000244|PDB:4LG9}.
FT   STRAND      290    294       {ECO:0000244|PDB:4LG9}.
FT   TURN        295    298       {ECO:0000244|PDB:4LG9}.
FT   STRAND      299    304       {ECO:0000244|PDB:4LG9}.
FT   STRAND      311    326       {ECO:0000244|PDB:4LG9}.
FT   STRAND      331    335       {ECO:0000244|PDB:4LG9}.
FT   STRAND      342    345       {ECO:0000244|PDB:4LG9}.
FT   STRAND      352    357       {ECO:0000244|PDB:4LG9}.
FT   STRAND      361    368       {ECO:0000244|PDB:4LG9}.
FT   STRAND      371    377       {ECO:0000244|PDB:4LG9}.
FT   STRAND      384    388       {ECO:0000244|PDB:4LG9}.
FT   STRAND      394    399       {ECO:0000244|PDB:4LG9}.
FT   STRAND      406    408       {ECO:0000244|PDB:4LG9}.
FT   STRAND      415    419       {ECO:0000244|PDB:4LG9}.
FT   STRAND      424    428       {ECO:0000244|PDB:4LG9}.
FT   TURN        429    432       {ECO:0000244|PDB:4LG9}.
FT   STRAND      433    438       {ECO:0000244|PDB:4LG9}.
FT   STRAND      445    450       {ECO:0000244|PDB:4LG9}.
FT   STRAND      454    461       {ECO:0000244|PDB:4LG9}.
FT   STRAND      464    470       {ECO:0000244|PDB:4LG9}.
FT   TURN        471    473       {ECO:0000244|PDB:4LG9}.
FT   STRAND      476    481       {ECO:0000244|PDB:4LG9}.
FT   STRAND      486    491       {ECO:0000244|PDB:4LG9}.
FT   STRAND      495    502       {ECO:0000244|PDB:4LG9}.
FT   STRAND      507    511       {ECO:0000244|PDB:4LG9}.
SQ   SEQUENCE   514 AA;  55595 MW;  0B556D2EE4BA796D CRC64;
     MSISSDEVNF LVYRYLQESG FSHSAFTFGI ESHISQSNIN GALVPPAALI SIIQKGLQYV
     EAEVSINEDG TLFDGRPIES LSLIDAVMPD VVQTRQQAYR DKLAQQQAAA AAAAAAAASQ
     QGSAKNGENT ANGEENGAHT IANNHTDMME VDGDVEIPPN KAVVLRGHES EVFICAWNPV
     SDLLASGSGD STARIWNLSE NSTSGSTQLV LRHCIREGGQ DVPSNKDVTS LDWNSEGTLL
     ATGSYDGFAR IWTKDGNLAS TLGQHKGPIF ALKWNKKGNF ILSAGVDKTT IIWDAHTGEA
     KQQFPFHSAP ALDVDWQSNN TFASCSTDMC IHVCKLGQDR PIKTFQGHTN EVNAIKWDPT
     GNLLASCSDD MTLKIWSMKQ DNCVHDLQAH NKEIYTIKWS PTGPGTNNPN ANLMLASASF
     DSTVRLWDVD RGICIHTLTK HQEPVYSVAF SPDGRYLASG SFDKCVHIWN TQTGALVHSY
     RGTGGIFEVC WNAAGDKVGA SASDGSVCVL DLRK
//
